U.S. regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy. The Food and Drug Administration approved a 7.2-milligram dose of Novo Nordisk's semaglutide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results